Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1868 studies found for:    "Melanoma"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Prospective Melanoma Database
Condition: Melanoma
Intervention: Other: clinical biological data collection on melanoma
2 Completed EF5 in Melanoma Patients
Condition: Melanoma
Intervention: Drug: EF5 Hypoxia
3 Recruiting Characterization of the Melanoma-Specific Immune Response
Condition: Melanoma
Intervention:
4 Terminated Early Diagnosis of Melanoma Using Expression Profiling and Non-Invasive Sampling of Skin Cells
Condition: Melanoma
Intervention: Other: EGIR Tape
5 Recruiting Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)
Condition: Melanoma
Intervention:
6 Terminated Safety Study of Human IgM (MORAb-028) to Treat Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: MORAb028
7 Recruiting Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Stage IV Melanoma
Condition: Melanoma
Interventions: Drug: All-Trans Retinoic Acid;   Drug: Ipilimumab
8 Completed
Has Results
Melanoma Perception and Health Literacy in People of Color
Condition: Melanoma
Interventions: Behavioral: ABCDEs of Melanoma Skin Cancer;   Behavioral: ABCDEs of Melanoma
9 Recruiting A Clinical Trial of Patients With Melanoma
Condition: Melanoma
Interventions: Drug: Digoxin Combination;   Drug: Dabrafenib;   Drug: Trametinib
10 Completed Haploidentical NK Cell Infusion in Malignant Melanoma
Condition: Melanoma
Intervention: Biological: Haploidentical NK cell
11 Active, not recruiting Vaccination Plus Ontak in Patients With Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: 4-peptide melanoma vaccine;   Drug: 4-peptide melanoma vaccine plus Ontak;   Drug: ontak
12 Completed Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma
Condition: Melanoma
Interventions: Biological: dendritic cell-MART-1 peptide vaccine;   Procedure: leukapheresis
13 Terminated Vaccination of Melanoma Patients With Total or CD25-depleted Peripheral Blood Mononuclear Cell (PBMC)
Condition: Melanoma
Interventions: Biological: PBMC re-infusion;   Biological: CD25 depletion
14 Completed Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion
Condition: Melanoma
Intervention: Drug: Temozolomide
15 Completed
Has Results
Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma
Condition: Melanoma
Interventions: Biological: bevacizumab;   Drug: erlotinib hydrochloride;   Genetic: fluorescence in situ hybridization;   Genetic: gene expression analysis;   Other: immunologic technique;   Other: laboratory biomarker analysis;   Procedure: biopsy
16 Completed
Has Results
Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)
Condition: Melanoma
Interventions: Drug: Temozolomide;   Drug: Dacarbazine
17 Active, not recruiting LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma
Condition: Melanoma
Interventions: Drug: LGX818;   Drug: MEK162;   Drug: LEE011;   Drug: BGJ398;   Drug: BKM120;   Drug: INC280
18 Recruiting A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
Condition: Melanoma
Interventions: Drug: Vemurafenib;   Drug: Metformin
19 Recruiting Study Assessing Two Models of Hypofractionated Protontherapy on Large Choroidal Melanomas
Condition: Melanoma
Intervention: Radiation: Protontherapy
20 Terminated Imatinib in Adult Patients With Metastatic Ocular Melanoma
Condition: Melanoma
Intervention: Drug: Imatinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.